trending Market Intelligence /marketintelligence/en/news-insights/trending/IOoQAbP7qQlLmCEgFoO6fg2 content esgSubNav
In This List

Verastem appoints chief medical officer

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Verastem appoints chief medical officer

Verastem Inc. appointed NgocDiep Le as chief medical officer.

Le joins Verastem from AstraZeneca PLC unit MedImmune Inc. where she served as vice president, immuno-oncology innovative medicines.

She previously served as global clinical program head and executive medical director at Novartis AG's oncology unit.